(1)...3 (2)...5 (3)...6 (4) (1)...9 (2)...10 (3)...13 (4) 14 (5) (1)...16 (2) (1)...21 (2)...22 (3)
|
|
- せとか なかじゅく
- 5 years ago
- Views:
Transcription
1
2 (1)...3 (2)...5 (3)...6 (4) (1)...9 (2)...10 (3)...13 (4) 14 (5) (1)...16 (2) (1)...21 (2)...22 (3) (1)...26 (2)...28 (3)...30 (4)...31 (5)...35 (6)...38 (7) (1)...43 (2)...44 (3) (1)...46 (2)...47 (3) (1)...54 (2) (1)...63 (2)...64 (3)...69 (4)...70 (5) (1)...79 (2)...82 (3)...84 (4)...85 (5) (1)...90 (2) OEM..91 (3)...92 (4)...92 (5)...93 (6) (1)...99 (2) (3) (4) (5) (6) (7) (8) (9) (1) (2) (3) (4) (5) (6)
3 1
4 2
5
6 Eucomed EU EU GDP Medical Devices Experts Group, Report On The Functioning of The Medical Devices Directive: Final report corr 1. EU 4
7 GDP , =100 5
8
9 ,
10 OECD 2000 GDP OECD
11 10 9
12
13
14 (2) 12
15 ) (2)(3) )
16 MRI CT
17
18 ,309 1,
19 , % 3, , ,
20 18
21 1, % % ,
22
23 EMI CT 1978 MRI CT MRI PET CT MRI 5 (*)
24 '50 '51 '58 ME 1960 '62 70 '72 CT 1970 '74 PTCA 80 '78 MRI 1980 ' IVR PET ESWL DDS 2001 IVR DDS 22
25 IVR IVR PTA 1974 PTCA
26 IVR 24
27 25 a) b) c)dds d) e) f) g) h) i) QOL 2001 DDS
28 2000 2,576 53, , , , ,
29 27
30 ,286 2,349 1,169 1,218 96,604 90, ,349 2, EU medical technology business entities Eucomed 28
31 29
32 2000 1,580 1, ,
33 Medical Device & Diagnostic Industry
34 CT 32
35 1 () X CT MRI 2 ()MRI CT X X TV 3 () CT X TV 4 () X X X X II X TV X X X X ECT CT 5 () X X X 6 X CT X / C () IT MR 7 X CT MRI () X 8 X X CT () X TV X X ECT CT 9 COMPUTED RADIOGRAPHYCR X () 10 () 11 () 12 () 13 () 14 () 15 () 16 () 17 () 18 () 19 () 20 () 33
36 21 () 22 () 23 () 24 () 25 () 26 () 27 () 28 () 29 () 30 () 31 () 32 () 33 () 34 () 35 () 36 () 37 () 38 () 39 () 40 () 41 () 42 () 43 () 44 () CT 45 () 46 () 47 () 48 () 49 () 50 ()
37 5000 1,
38
39
40
41 (4) 39
42 40
43 41
44 42
45 ,932 8, ,170 3,
46
47 , ,
48
49 47 (*) 2000
50 48
51 49
52 1,700 1, IVR
53 95 MRI
54 (3) 52
55 53
56
57 ,712 2, ,
58 PTCA (*) (**) (*) 11 (**)
59
60 58
61
62 ODA 60
63 (a) BECON (b) (c) NIH 12 4 BECON (*) METIS (*) Bioengineering Consortium 1997 NIH 61
64 62
65 63 1) 2) 3) 4) 5) 6) GMP 7) 8)
66 64 9) 10) PL PL 11) 12) 3) 9) 2) 10) 11) 12) 14
67 MRI GCP GMP GPMSP GCP GMP GPMSP 65
68 * PTCA * FDA
69 12 GMP GPMSP 67
70 68
71 FDA 1998 BAA 69
72 70 GDP ,500 35
73 ,668 1, ,800 8, ,600 1, , , ,630 9,600 7,470 63,700 20,500 19, , ,920 14
74 FDG 7, ,660 1,140 (2)) ,490, , , ,420, , , ,360, , ,000 1,310, , ,
75 C2 73
76 74,700 74
77 GDP (*) (**) (*) Diagnosis Related Group / Prospective Payment System 500 DRG (**) DRG/PPS
78
79 24 77
80 No , No , , G No I No PL No PTCA
81 (5) QOL 79
82 TLO 80
83 81
84
85 OEM 83
86 M&A
87 )5) 1 3) 5) 1) 1 2) 1 3) OEM 4 4) 1 5) 4 6) 1 5) 5) 6) 1)2) 85
88 86 1 OEM 1 1
89
90 1) 2) 3) 4)PL FDA 88
91
92 OEM (4)
93 OEM OEM OEM OEM OEM 91
94 92
95 93
96 94
97 1 6, OEM
98 ,
99 (4) (1) 97
Microsoft Word 年度DPCによるSPECT検査動向に関する報告 _02表紙.doc
DPC SPECT 2 2013 9 DPC/PDPSDiagnosis Procedure Combination / Per-Diem Payment System 1 DPC DRG/PPS: Diagnosis Related Groups / Prospective Payment System 2003 2008 7 2008 DPC 2012 1,500 DPC SPECT 70% DPC
More informationscience
science IT PERSON TO PERSON EU IT IT WHO TV I T Harvard University Brigham and Women s Hospital, Renal Division UCSF CT MRI IT 1 40 17 3 27 Winslow 1949 Impact Factor 50 1 16 1 NIH Samuel W. Cushman
More informationuntitled
DNA GDP GDP Brooks Adams, America s Economic Supremacy, 1900 BRICS WHO pain TV ABC SSRI GM GM IT IC INDIACHINA WHO GDP WHO OECD GDP WHO, World Health Report 2000, OECD Health Data 2003. GDP OECD GDP OECD
More information天草郡市医師会第139回(臨時)代議員会
A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (
More information26 multiculturarism 25 EU 21
2 IOM NGO integration assimilation 25 26 multiculturarism 25 EU 21 IOM 27 5 10 28 13 8.9 734 200 187 100 33 1990 460 1,420 960 2003 76 9,000 62 6,000 500 2003 76 9,000 13 3,000 EU EU EU EU 7 EU EU 200
More informationuntitled
2000 2003 2004 DPC Continuum Care 32 IT HIPPA 18 IT MSW MSW MSW 18 HIPPAHealth Insurance Portability and Accountability Act of 1996 33 2002 34 1985 A B C 1020 D E F 35 A B IT A B DPC 36 RUG 19 19 RUGResource
More information1 発病のとき
1 3 2002 11 26 27 5 2003 1 15 16 9 2003 4 16 17 10 2003 6 25 26 12 2003 9 17 13 2003 11 12 13 16 2004 4 21 22 17 2004 5 19 20 18 2004 6 15 17 2004 6 17 20 2004 7 14 15 21 2004 8 18 19 2004 8 19 22 2004
More information19 3 6 4 65 50 2 1 25.018.716.2 15.0 7 70.17.9 8 44.242.3 50.6 5 23.3 35.7 2 1 (SA) 2 (SA) 6 4 3 (SA) PTA 4 (SA) 7 50 5 (SA) 4 6 (3 ) 7 (SA) 8 2 1 8 3 30 50 9 (SA) 5 60 10 (SA) 2 11 (SA) 12 (MA) 40 13
More information3.....ren
823 2011 329 20 11 20 48.3 90.5 20 40 21 12 16 22 3 23 50 50 50 1 54 2 55 3 56 57 49 330 823 2011 6 0.3 0.7 1.0 3 1 0.3 0.7 1.0 5 m 3 m 3 m 5 m 5 3 m 1 2 5001,000 3 50 52 mm 4 0.1 1 50 823 2011 331 5 10
More information第4章 ポーランド
20 20 90 90 18 20 77 20 30 1939 200 78 79 39 80 1 50 70 50 56 70 70 81 70 10 73 71 10 80 240 70 80 10 80 81 79 82 82 80 86 80 80 87 89 82 89 250 89 90 2 500 90 83 EU PHARE 90 93 16 3 90 91 4 92 90 84 10
More information次世代育成支援行動計画
15 7 10 300 9 17 21 5 21 22 5 1 2 3 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 16 39 40 11 2 3 P P 41 42 13 3 70.4 86.0 33.3 35.1 75.3 91.5 28.8 36.2 49.0 28.7 14.0 10.0
More information86 7 I ( 13 ) II ( )
10 I 86 II 86 III 89 IV 92 V 2001 93 VI 95 86 7 I 2001 6 12 10 2001 ( 13 ) 10 66 2000 2001 4 100 1 3000 II 1988 1990 1991 ( ) 500 1994 2 87 1 1994 2 1000 1000 1000 2 1994 12 21 1000 700 5 800 ( 97 ) 1000
More information6 1873 6 6 6 2
140 2012 12 12 140 140 140 140 140 1 6 1873 6 6 6 2 3 4 6 6 19 10 39 5 140 7 262 24 6 50 140 7 13 =1880 8 40 9 108 31 7 1904 20 140 30 10 39 =1906 3 =1914 11 6 12 20 1945.3.10 16 1941 71 13 B29 10 14 14
More information1章
... 1... 1... 1... 2... 2... 3... 3... 6... 10... 14... 18... 19... 20... 23... 29... 29... 33... 40... 47... 48... 48... 54... 54... 59... 61 ... 63... 65... 65... 66... 66... 69... 71... 107 1 2 3 //
More information4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2
5 2006 9 1 A) 1 2 3 4 B) 1 2 3 4 5 2 A) GDP 7.9 B) 31 25 8 10 1 45 3 31 8 2 70 1 4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 1.6 3 31.1 4 2 5 3 4 CT MRI PET 1 30 A) 1 2 6 B) 1 2 3 4 5 3 90.5
More informationuntitled
IEEJ 1 IEEJ CO / 2 / CO / 3 4 2004 A B C D E F G 1 1 1 3 28 61 0 93 2 120 274 76 0 0 0 469 3 121 275 78 28 61 0 563 4-3 -18-0 0 0 0-21 5 118 256 78 28 61 0 542 6-54 -16-50 -21-61 80-121 7-19 -17 0-7 0
More informationがん診療におけるFDG FDG-PET/CTの役割
PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT
More information1 2 3 4 5 1 1:30 NPO 16 1 19 16 2 17-6 - 10 2008 2010 120 150 IT( ) 60 21 40-7 - - 8-10 ( ) NPO 2 10 16:40-9 - 10 ii NPO NPO ( ) ( ) 11 12 13 14 15 22 26 27 28 29 30 31 32 33 34 m3 m3
More information32 TEL: 0959-52-3000 FAX: 0959-52-4467 Email: nkh@orange.ocn.ne.jp URL: http://www.kamigoto-hospital.jp/ 1 73 MRI IT IVR PTCA 74 MC CT) NECMega-Ork 75 Web HTLV-IATL 2 ICU Holter MD-C T MRIX DSAFCR 3 4
More information第2巻/1-5
79 32 6 80 1998 1997 4 PTA 80 1 2 5 81 82 3 82 14.9 1 51.9 33.8 58.4 26.3 14.5 59.4 21 PTA 5 83 3 84 3 3 5 85 52.5 PTA 9,864 11 39 105 120 2,099 2,763 3 2 38 26 24 86 4 1 17 5 87 88 3 2,000 110 1991 5
More informationDAC A DAC 2001 2001 1.90 2.52 0.44 0.60 0.94 0.20 0.69 DAC 144 111 OECD 1999 2001 144 18.2 1.0 882 ( 192 ) 176 14 39 19 21 22 18 0.8 1 1979 1 2
ODA 1979 ODA ODA ODA 1985 2001 ODA 1990 1990 2001 2000 1972 2002 1212 ODA DAC 1999 12 2600 500 5900 4600 IDA 4 700 CEC 4000 UNDP 1600 DAC DAC A 1 DAC A DAC 2001 2001 1.90 2.52 0.44 0.60 0.94 0.20 0.69
More information資料・医療制度改革をめぐる論点
..3..8..8 16 19 1 22 22 24 25 IT 27 28 2 12 30 3583 7.98 (1) 36 14 102 14 7 26 3 2 1 70 75 3 5 (2) (3) (4) 14 12 17 7 15 1 15 7 119 (1995 ) 1863,1995.2.1, pp.36-37. 124 1863,1995.2.1, pp.35-36. 329 4 1
More information1 z q w e r t y x c q w 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 R R 32 33 34 35 36 MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR
More information, ,
41 42 73 121 121 10 122 11 122 12 131 13 131 15 10 133 16 11 133 17 12 136 18 13 141 19 14 141 20 15 146 21 16 149 22 17 149 23 174 18 24 73 19 241,301 25 20 242,301 (1) 26 21 331 27 22 241,341 28 23 242,341
More information1
1 5% 4% 11% 8% 13% 12% 10% 6% 17% 6% 8% 4% 6% 6% 2% 17% 17% 12% 14% 16% 6% 37% 11% 17% 35% 2 (N=6,239) 0 200 400 600 800 1,000 1,200 1,400 1,600 1,800 1,585 1,126 950 494 345 296 242 263 191 150 131 116
More informationuntitled
61 62 18 19 10 20 21 22 63 23 24 64 65 EU 100 66 ? ( )? 1999 2 22? 1 1? 67 9 0 6 8 9 1 1 1 Java? 1 2 3 5 4 9 8 2 3 5 II 4 4 4 5 II 1 I 68 II (?) 9 2 2 1 1 2 2 3 4 4 5 5 5 3 4 11 2 1 2 69 10 2F 2F 6 2 11
More information1 1981 X FCR Fuji Computed Radiography 1983 25 FCR CR Computed Radiography 2009 CR X X CR CR GE CR 1980 CR 6 CR CR CR FCR 1 2-1 FCR FCR X X 1895 X X X
ISSN 1347-4448 ISSN 1348-5504 10 11 2011 11 X FCR E-mail: miki@rikkyo.ac.jp E-mail: koh@center.konan-u.ac.jp X X X X Fuji Computed Radiography 2011 Global Business Research Center www.gbrc.jp 775 2011
More information平成14年度 湘南市の将来都市像研究報告
...1...1...1...2...6...8... 10... 10... 11... 13... 16... 18... 20... 21... 21... 21... 21... 22... 23... 24... 25 21... 26... 27... 28 21... 29... 30... 31... 32... 37 20km 1 1 5 30.3ha 6.3ha 23.8ha
More information1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ( ) 24 25 26 27 28 29 30 ( ) ( ) ( ) 31 32 ( ) ( ) 33 34 35 36 37 38 39 40 41 42 43 44 ) i ii i ii 45 46 47 2 48 49 50 51 52 53 54 55 56 57 58
More informationuntitled
i ii (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (2) (3) (1) (2) (3) (1) (1) (1) (1) (2) (1) (3) (1) (2) (1) (3) (1) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3)
More information平成18年度「商品先物取引に関する実態調査」報告書
... 1.... 5-1.... 6-2.... 9-3.... 10-4.... 12-5.... 13-6.... 15-7.... 16-8.... 17-9.... 20-10.... 22-11.... 24-12.... 27-13... 29-14.... 32-15... 37-16.... 39-17.... 41-18... 43-19... 45.... 49-1... 50-2...
More information23 15961615 1659 1657 14 1701 1711 1715 11 15 22 15 35 18 22 35 23 17 17 106 1.25 21 27 12 17 420,845 23 32 58.7 32 17 11.4 71.3 17.3 32 13.3 66.4 20.3 17 10,657 k 23 20 12 17 23 17 490,708 420,845 23
More informationスライド 1
2030 (2004) 1 2 3 1 212004 5.5203031 (1) 2004GDP () 2030GDP )1 2122005 21 2 ASEAN+5 3 207.3EU8.03.3 (2004) 4 10 22.8 16.11 121,006 100 593,369 100 19,715 16 247,813 42 34,217 28 88,772 15 6,832 6 43,746
More information[ 708 ] , EU 48 OECD OECD
2013 7 540-0011 http://www.osaka.doyu.jp 1 2014 26 2757 [ 708 ] 33 1 2013 4 1 42,858 1990 2 2001 38 86 2000 EU 48 OECD 2004 6 2 OECD 2003 5 2010 2 2010 6 18 21 2 21 2013 4 1 499 416 15.1 0 4 933 33.8 783
More informationVol. 47, No. 1, January 2001
1997 99 GDP 10.7 % 1 1 9 2 1,526 97 2 4 3 98 GDP 5.8 % 4 21 21 29 5 8 6 1970 30 Vol. 47, No. 1, January 2001 OEM 7 1980 R&D 8 100 80 50 9 10 flexible specialization 2 industrial divide 11 31 12 IT IT 21
More information10Disclosure_H0104_0618
01 SHIZUOKA BANK GROUP REPORT 2010 SHIZUOKA BANK GROUP REPORT 2010 02 03 SHIZUOKA BANK GROUP REPORT 2010 SHIZUOKA BANK GROUP REPORT 2010 04 05 SHIZUOKA BANK GROUP REPORT 2010 06 SHIZUOKA BANK GROUP REPORT
More informationuntitled
GLPGCP GLPGCP 16 915 335 300 EU GMP 2 B B GMP GMP H.5 GCP GCP H.2 H.9 H.15 H.17 GCP GCP / GCP GCP GCP GCP GCP GCPGCP 8 GCP GCPGCP 9 GCP GCPGCP 10 GCP GCP GCP GCP GLP LP GLP 3 4 6 FDA GVP Essential
More information(資料2)第7回資料その1(ヒアリング概要)
2 3 4 5 6 7 8 9 10 11 12 13 1 1 1 1 5 1 6 533 4 505 722 13 3325 475 1 2 3 13 10 31 1 1 1 (1) 1 (2) 2 (3) 3 (4) 4 5 5 6 7 8 8 8 9 11 11 12 13 14 15 16 19 (1) (2) (3) (1) (5 ) 1 (10 ) ( ) (2) 2 4 (3) 3 3,100
More informationIT 180 181 1) 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 (a) (b) (c) (d) (e) (f) (a) (a) (b) 214 215 216 (a) (a) (a)
More information-------------------------- ----------------------------------------------------- -------------------------------------------------------------- ----------------------------------------------------- --------------------------------------------------------------
More information<4D F736F F D DEC8BC A95BD90AC E A982BA81698AB A B B4790DF90AB8EBE8AB FC89408A4F816A82CC93AE8CFC82C98AD682B782E9838C837C815B D
27 29 2 IT 1,234 1,447 2,130 1,200 3,043 4 3 75 75 70-74 -10 J00 J101 J110 J111 J118 J300 J302-304 J301 26,475,118 155,290,311 1,234 14,472,130 75,784,748 12,003,043 79,505,563 1 1.00% 0.62% 1.31% 9 12
More information, , ,210 9, ,
2006 5 642 7 2,671 35 732 1,727 602 489 386 74 373 533 305 1,210 9,786 2004 1,024 43.7 16.4 2004 978.6 40.2 2003 1 2006 5 1997 1998 1999 774 3,492 11 2,603 35 843 5,118 1,686 476 358 2000 738 3,534 11
More informationB B 10 7 581 10 8 582 10 9 583 B B 10 11 585 10 12 586 B 10 10 584 B
10 1 575 10 12 586 B B 10 1 575 10 2 576 B B 10 4 578 10 5 579 10 3 577 B 10 6 580 B B B 10 7 581 10 8 582 10 9 583 B B 10 11 585 10 12 586 B 10 10 584 B 11 1 587 11 12 598 B B 11 1 587 11 2 588 11 3 589
More informationMicrosoft Word - MedicalMonthlyREPORT2011年10月
1/11 Medical Monthly REPORT 2011 10 株 式 会 社 夢 みらい [2011/10/13 ] [2011/10/13 ] [2011/10/13 ] [2011/10/12 ] [2011/10/12 ] [2011/10/10 ] [2011/10/10 ] 2/11 3/11 [2011/10/7 ] [2011/10/7 ] [2011/10/7 ] [2011/10/6
More information2
1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem
More information: Voice V 2009 GDP 02% OECD 3 LG FTA EU FTA TPP 2010a b ? Focus
: 80 1 2011 7 2010 1 25 2010.4.13Voice2010 6 2010 7 31 V 2009 GDP 02% OECD 3 LG 2009 8 1 FTA EU FTA TPP 2010a 2 1 2010b 12 15 2011?5512011 Focus Point2 9 2010 2010 221 1997 59 80 1 2009 20112010 80 2010
More information104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26
25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (
More informationARCリポート (RS 8 9 0 ) 禁 複 製 社 内 限 り 日 本 の 医 療 機 器 産 業 振 興 と 製 造 物 責 任 法 (PL 法 )の 関 係 について 世 界 の 医 療 機 器 市 場 が 拡 大 している 中 で 日 本 の 医 療 機 器 市 場 は 停 滞 しているだけでなく 心 臓 ペースメーカーを 始 めとする 高 価 な 機 器 に 関 しては 欧 米 企 業
More information飯能市と名栗村の新しいまちづくり計画に関する住民意識調査
- 1 - - 2-299 299 299 - 3-299 299 - 4-30 299 299 JR - 5-10 299 299 12 JR 2K JR - 6 - R299 R299 299 27 299 299 JR - 7 - JR 50 1 2 20 299 299 - 8-299 --- 299 70 299 - 9-299 299 33 - 10 - TV 2/ 299 299 -
More informationNIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml
NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008
More information>Tokyo Dome Group Business Report 2010:
A Promising Future Tokyo Dome Group Business Report 2010 >Tokyo Dome Group Business Report 2010: 79.4% 69,870 91.7% 256,267 8.9% 7,869 1.3% 3,836 11.5% 10,153 6.9% 19,318 1 >Tokyo Dome Group Business Report
More information20●12頁●6-14▲放射線科▲.ppt
No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%
More information医療機器指令 93/42/EEC の概要(第2版)
93/42/EEC ( 2 ) e 2013 10 2 1 2 1.1.............. 2 1.2...... 2 2 2 2.1....... 3 2.2... 3 2.3......... 3 3 3 3.1...... 3 3.1.1............ 4 3.1.2.......... 4 3.2.............. 5 3.2.1......... 5 3.2.2.............
More information,829 [ 633 ] , EU 48 OECD OECD
2009 7 24 540-0011 http://www.osaka.doyu.jp 1 2010 22 2,829 [ 633 ] 33 1 2009 4 1 40,942 1990 2 38 86 2000 EU 48 OECD 2004 6 OECD 21 2 21 2009 4 1 499 393 13.9 0 4 915 32.3 780 27.6 500 999 123 4.3 5 9
More informationSBSGroup_CSR_h01-h04_0820CS5.ai
CSR Report 2015 SBS GROUP CSR REPORT 2015 1 CSR Report 2015 Contents 3 11 19 22 5 7 15 17 21 2 SBS GROUP CSR REPORT 2015 3 4 SBS GROUP CSR REPORT 2015 5 6 SBS GROUP CSR REPORT 2015 7 8 SBS GROUP CSR REPORT
More information韓国の教育自治
2002 7 1 i 3 1 2 66.7 66.0 19.3 0.2 13.7 ii 27 2002 1 1997 5 18 30 19 2 24 26 28 25 1 3 5 2002 3 8.9 4 25 9 446 2002 8,308 6,698 806 1996 2002 39 13799 2 3 10 26 137 2002 6 11 12 13 14 15 16 23 28 22 27
More information44-1(前11)7回春季大会
PET 5 18 5 20 5 18 5 20 5 18 5 20 5 18 5 20 5 18 17:10 18:35 19 5 18 20 URL: http://www.t-inform.co.jp/jsnm-s7/ 7 http://www.t-inform.co.jp/jsnm-s7/ 7 19 5 18 20 7 7 PET PET PET RI 2 19 PET PET PET 1
More information20113 2011513 1 20113 20113 P/L () 20103 20113 8,613 9,369 756 9% 122 180 58 48% 82 143 61 73% 35 92 56 160% () 53 51-2 -3% 2011 20113 B/S B/S 0.6pt -4% -10% 1.2pt 15% 8% -3% 3.8 1,094 1,931 7.3% 289
More information03_学術.indd
Arts and Sciences PET/CT PET/CT System in The EMR and PACS hospital 1 24359 2 44769 1 2 Key words: (1) PET/CT, (2) EMR, (3) HIS, (4) RIS, (5) PACS Summary The PET/CT inspection was started under an electronic
More information1
1 2 4,000 (HKICL)HKICLHKMA HKICL 3 20041 20077 200812 20096 20097 20099 () 7 60 2010 7 20118 201110 201112 20126 20128 20136 201411 7100 4 20008 100 222 19,347 20034 37 5.85 529 20076 199 7,327 12,717
More information1
1 3 2008 4 19 69 20 82 12241251 IRB IRB CRC CRC 2000 EDC 2 baseline 19 20 Network draft protocol feasibilitystudy 20 CCR 1 9 timeline 40 coordinating centre Minnesota e-learning seminar 3 114 125 144 67
More informationCRC CRC CRC No F TEL : FAX : URL :
CRC CRC CRC No.18 2004 5 103-0023 3-4-1 5F TEL : 03-5200-2681 FAX : 03-5200-2684 E-mail : onozuka-opir@jpma.or.jp, asaka-opir@jpma.or.jp URL : http://www.jpma.or.jp/opir/ 1.... 1 2.... 2 2.1... 2 2.1.1...
More informationuntitled
2009/5/8 ICIDH ICIDH ICIDH ICF ICF ICIDH1980, WHO Impairment impairment Disabilityisability disability handicap Handicapandicap ICIDH ICIDH ICIDH 1 ICIDH 1995 1996 1997 1998 1999 2000 2001 London Madrid
More information- 1 -
19 21 - 1 - - 2 - - 3 - - 4 - 19 21 21 2224-5 - 19 2007 21 2009 H18 H27 18 27 10 H18 H22 18 22 22 H19 H21 19 21 21-6 - 20 21 19 2,449,254 2,495,506 1.9% 2,603,427 4.3% 1,593,428 1,582,704 0.7% 1,552,160
More information1. 3 2. 2 7 3. 10 4. 12 5. 15 6. 18 7. 21 8. 24 9. 28 10. 31 11. 34 12. 38 13. 41 14. 44 15. 47-1 - 16. LET S TRY 50 17. 52 18. 55 19. K 58 20. TAWASHI 62 21. 65 22. 68 23. 72 24. Student Venture Project
More information